Clinical trial of insulin-like growth factor-1 in Phelan-McDermid syndrome

BACKGROUND: Phelan-McDermid syndrome (PMS) is caused by haploinsufficiency of the SHANK3 gene and is characterized by global developmental delays and autism spectrum disorder (ASD). Based on several converging lines of preclinical and clinical evidence supporting the use of insulin-like growth facto...

Descripción completa

Detalles Bibliográficos
Autores principales: Kolevzon, A., Breen, M. S., Siper, P. M., Halpern, D., Frank, Y., Rieger, H., Weismann, J., Trelles, M. P., Lerman, B., Rapaport, R., Buxbaum, J. D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994375/
https://www.ncbi.nlm.nih.gov/pubmed/35395866
http://dx.doi.org/10.1186/s13229-022-00493-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994375/
https://www.ncbi.nlm.nih.gov/pubmed/35395866
http://dx.doi.org/10.1186/s13229-022-00493-7

Ejemplares similares